Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for WT1_MTF1_ZBTB7B
Z-value: 13.14
Motif logo
Transcription factors associated with WT1_MTF1_ZBTB7B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WT1
|
ENSG00000184937.16 | WT1 |
|
MTF1
|
ENSG00000188786.10 | MTF1 |
|
ZBTB7B
|
ENSG00000160685.13 | ZBTB7B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZBTB7B | hg38_v1_chr1_+_155002630_155002689 | 0.75 | 2.8e-41 | Click! |
| WT1 | hg38_v1_chr11_-_32435360_32435419 | 0.37 | 1.1e-08 | Click! |
| MTF1 | hg38_v1_chr1_-_37859583_37859609 | -0.20 | 3.2e-03 | Click! |
Activity profile of WT1_MTF1_ZBTB7B motif
Sorted Z-values of WT1_MTF1_ZBTB7B motif
Network of associatons between targets according to the STRING database.
First level regulatory network of WT1_MTF1_ZBTB7B
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 61.1 | 305.7 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 49.0 | 293.8 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 47.1 | 141.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 47.0 | 140.9 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 43.6 | 174.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 43.2 | 129.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 40.6 | 40.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 37.4 | 112.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 36.8 | 110.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 36.0 | 144.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 35.7 | 178.6 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 34.6 | 138.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 34.6 | 207.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 34.3 | 34.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 33.3 | 665.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 33.0 | 99.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 32.7 | 131.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 32.6 | 32.6 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 32.2 | 96.5 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 31.4 | 282.7 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 31.0 | 123.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 30.8 | 92.4 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 30.4 | 91.3 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 29.0 | 144.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 28.9 | 57.8 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 27.1 | 81.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 27.1 | 27.1 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 26.9 | 80.7 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 26.9 | 107.5 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 26.2 | 78.6 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 26.2 | 26.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
| 25.7 | 333.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 25.7 | 102.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 25.0 | 224.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 24.8 | 74.3 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 24.6 | 49.2 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 24.4 | 24.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 24.4 | 122.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 24.3 | 121.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 24.3 | 72.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 23.9 | 95.5 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 23.8 | 23.8 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 23.6 | 117.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 23.6 | 70.7 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
| 23.3 | 46.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 23.1 | 115.5 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 23.1 | 92.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 23.0 | 68.9 | GO:0036049 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 22.9 | 91.6 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 22.4 | 67.1 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 22.1 | 110.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 22.1 | 66.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 22.0 | 66.0 | GO:0001757 | somite specification(GO:0001757) |
| 21.6 | 64.7 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 21.0 | 63.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 21.0 | 21.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 21.0 | 41.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 20.7 | 124.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 20.6 | 61.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 20.5 | 123.0 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 20.1 | 100.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 19.9 | 39.8 | GO:0008354 | germ cell migration(GO:0008354) |
| 19.9 | 19.9 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 19.7 | 59.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 19.7 | 59.0 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 19.5 | 19.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 19.5 | 19.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 19.5 | 38.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 19.3 | 58.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 19.0 | 76.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 19.0 | 94.8 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 18.8 | 56.5 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 18.7 | 18.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 18.5 | 55.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 18.4 | 55.2 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 18.2 | 54.6 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 18.2 | 108.9 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 17.9 | 89.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 17.7 | 70.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 17.7 | 17.7 | GO:1903059 | positive regulation of lipoprotein metabolic process(GO:0050747) regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 17.6 | 228.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 17.6 | 158.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 17.4 | 87.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 17.3 | 34.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 17.3 | 103.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 17.1 | 51.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 17.0 | 101.7 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 16.9 | 101.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 16.8 | 151.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 16.8 | 67.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 16.8 | 16.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
| 16.7 | 33.4 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 16.7 | 66.7 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 16.6 | 49.9 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 16.6 | 83.2 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 16.5 | 16.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 16.4 | 82.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 16.3 | 16.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 16.2 | 146.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 16.2 | 64.9 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 16.2 | 129.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 16.2 | 48.5 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 16.0 | 144.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 15.7 | 15.7 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 15.6 | 77.9 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 15.6 | 15.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 15.5 | 186.2 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 15.5 | 77.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 15.5 | 77.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 15.4 | 153.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 15.3 | 92.1 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 15.3 | 30.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 15.2 | 91.3 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 15.2 | 91.2 | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 15.2 | 45.5 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
| 15.1 | 120.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 15.0 | 30.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 14.9 | 59.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 14.9 | 44.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 14.9 | 29.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 14.8 | 133.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 14.7 | 102.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 14.6 | 14.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 14.6 | 14.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 14.5 | 14.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 14.4 | 14.4 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 14.4 | 71.8 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 14.4 | 114.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 14.3 | 14.3 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 14.3 | 71.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 14.2 | 28.4 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 14.2 | 56.8 | GO:0035627 | ceramide transport(GO:0035627) |
| 14.2 | 99.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 14.2 | 28.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 14.1 | 56.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 14.0 | 42.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 14.0 | 195.5 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 13.9 | 41.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 13.9 | 55.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 13.9 | 97.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 13.8 | 69.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 13.6 | 40.9 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 13.6 | 54.3 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) |
| 13.5 | 54.2 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 13.5 | 13.5 | GO:0060214 | endocardium formation(GO:0060214) |
| 13.5 | 40.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 13.3 | 13.3 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 13.3 | 79.8 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 13.3 | 53.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 13.2 | 79.3 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 13.1 | 365.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 13.1 | 91.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 13.0 | 91.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 13.0 | 13.0 | GO:1903802 | amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 12.9 | 193.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 12.9 | 77.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 12.8 | 38.5 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 12.8 | 63.9 | GO:0061324 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 12.7 | 38.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 12.7 | 63.6 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 12.7 | 114.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 12.6 | 87.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 12.5 | 37.6 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 12.4 | 24.8 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 12.3 | 592.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 12.3 | 245.9 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 12.3 | 36.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 12.2 | 48.8 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 12.2 | 36.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 12.1 | 36.4 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 12.0 | 48.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 12.0 | 71.9 | GO:0016926 | protein desumoylation(GO:0016926) |
| 12.0 | 35.9 | GO:0071812 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 11.9 | 119.5 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 11.9 | 83.5 | GO:1902075 | cellular response to salt(GO:1902075) |
| 11.9 | 47.6 | GO:1903610 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 11.9 | 130.8 | GO:0016322 | neuron remodeling(GO:0016322) |
| 11.9 | 11.9 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
| 11.8 | 94.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 11.8 | 11.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 11.7 | 116.6 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 11.6 | 23.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 11.6 | 150.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 11.6 | 34.8 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 11.6 | 81.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 11.6 | 23.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 11.6 | 23.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 11.5 | 114.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 11.4 | 57.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 11.4 | 125.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 11.3 | 34.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 11.3 | 136.0 | GO:0046958 | nonassociative learning(GO:0046958) |
| 11.3 | 22.7 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 11.3 | 11.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 11.3 | 45.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 11.3 | 22.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 11.3 | 462.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 11.2 | 224.1 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 11.2 | 22.3 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
| 11.2 | 189.8 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 11.1 | 100.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 11.1 | 111.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 11.1 | 22.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
| 11.1 | 22.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 11.0 | 187.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 11.0 | 21.9 | GO:0030035 | microspike assembly(GO:0030035) |
| 11.0 | 32.9 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 10.9 | 130.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 10.8 | 32.5 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 10.8 | 10.8 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 10.8 | 21.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 10.8 | 54.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 10.7 | 64.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 10.7 | 32.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 10.7 | 10.7 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 10.7 | 21.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 10.6 | 63.9 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
| 10.6 | 31.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 10.6 | 52.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 10.6 | 179.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 10.5 | 10.5 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 10.5 | 31.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 10.5 | 31.6 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 10.5 | 73.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 10.5 | 42.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 10.5 | 42.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 10.5 | 20.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 10.5 | 31.4 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
| 10.4 | 31.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 10.4 | 31.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 10.4 | 20.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 10.3 | 51.5 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 10.3 | 41.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 10.3 | 20.6 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 10.2 | 61.4 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 10.2 | 10.2 | GO:0072014 | proximal tubule development(GO:0072014) |
| 10.2 | 71.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 10.2 | 40.7 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 10.2 | 20.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 10.1 | 30.4 | GO:0060022 | hard palate development(GO:0060022) |
| 10.1 | 50.7 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 10.1 | 111.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 10.1 | 60.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 10.0 | 29.9 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 10.0 | 49.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 9.9 | 99.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 9.9 | 19.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 9.9 | 19.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 9.9 | 128.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 9.9 | 29.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 9.9 | 39.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 9.8 | 49.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 9.8 | 401.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 9.8 | 58.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 9.8 | 19.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 9.8 | 39.0 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 9.7 | 29.2 | GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 9.7 | 19.4 | GO:0035788 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 9.7 | 19.4 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 9.7 | 58.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 9.6 | 28.9 | GO:0060023 | soft palate development(GO:0060023) |
| 9.6 | 19.3 | GO:0060437 | lung growth(GO:0060437) |
| 9.6 | 19.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 9.6 | 28.9 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 9.6 | 76.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 9.6 | 19.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 9.6 | 28.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 9.6 | 28.7 | GO:1902365 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 9.6 | 258.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 9.5 | 47.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 9.5 | 28.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 9.5 | 28.6 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 9.5 | 66.6 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 9.5 | 85.5 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 9.5 | 28.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 9.5 | 18.9 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 9.5 | 66.2 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 9.5 | 28.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 9.4 | 85.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 9.4 | 56.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 9.4 | 28.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 9.4 | 9.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 9.4 | 65.6 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 9.4 | 262.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 9.4 | 18.7 | GO:0060032 | notochord regression(GO:0060032) |
| 9.4 | 9.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 9.3 | 18.7 | GO:0061461 | lysine transport(GO:0015819) lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transport(GO:1902022) L-lysine import into cell(GO:1903410) |
| 9.3 | 27.9 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 9.3 | 46.3 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 9.2 | 18.5 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 9.2 | 27.7 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 9.2 | 18.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 9.2 | 230.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 9.2 | 9.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 9.2 | 45.8 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 9.2 | 9.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 9.1 | 63.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 9.1 | 18.1 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 9.1 | 27.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 9.0 | 198.8 | GO:0097503 | sialylation(GO:0097503) |
| 9.0 | 36.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 9.0 | 72.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 9.0 | 72.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 9.0 | 98.8 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 9.0 | 26.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 8.9 | 35.8 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 8.9 | 17.9 | GO:2001202 | negative regulation of transforming growth factor-beta secretion(GO:2001202) |
| 8.9 | 499.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 8.9 | 169.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 8.9 | 17.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 8.9 | 26.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 8.9 | 35.5 | GO:0021759 | globus pallidus development(GO:0021759) |
| 8.8 | 44.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 8.8 | 26.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 8.8 | 35.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 8.8 | 26.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 8.8 | 61.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 8.7 | 17.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 8.7 | 69.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 8.7 | 209.0 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 8.7 | 113.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 8.7 | 69.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 8.6 | 8.6 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 8.6 | 8.6 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 8.5 | 501.3 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 8.5 | 254.9 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 8.5 | 67.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 8.5 | 42.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 8.4 | 33.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 8.4 | 41.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 8.3 | 49.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 8.3 | 49.8 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 8.2 | 123.6 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 8.2 | 57.3 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 8.2 | 163.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 8.2 | 65.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 8.2 | 32.6 | GO:1904139 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 8.2 | 16.3 | GO:0015808 | L-alanine transport(GO:0015808) |
| 8.1 | 32.6 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 8.1 | 8.1 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 8.1 | 138.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 8.1 | 8.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 8.1 | 8.1 | GO:0001554 | luteolysis(GO:0001554) |
| 8.1 | 105.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 8.1 | 8.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 8.1 | 16.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 8.1 | 32.3 | GO:0002159 | desmosome assembly(GO:0002159) |
| 8.0 | 87.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 8.0 | 31.8 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 7.9 | 15.9 | GO:0035973 | aggrephagy(GO:0035973) |
| 7.9 | 63.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 7.9 | 55.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 7.9 | 23.8 | GO:0001842 | neural fold formation(GO:0001842) |
| 7.9 | 23.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 7.9 | 23.7 | GO:0019075 | virus maturation(GO:0019075) |
| 7.9 | 15.7 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 7.9 | 23.6 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 7.8 | 15.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 7.8 | 77.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 7.8 | 31.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 7.8 | 46.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 7.7 | 7.7 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 7.7 | 139.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 7.7 | 38.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 7.7 | 15.4 | GO:0019086 | late viral transcription(GO:0019086) |
| 7.7 | 61.5 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 7.7 | 38.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 7.7 | 107.4 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 7.7 | 23.0 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 7.7 | 15.3 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 7.6 | 45.7 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
| 7.6 | 30.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 7.6 | 22.8 | GO:0060736 | prostate gland growth(GO:0060736) |
| 7.6 | 15.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 7.6 | 37.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 7.5 | 52.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 7.5 | 45.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 7.5 | 67.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 7.5 | 22.6 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 7.5 | 52.6 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 7.5 | 52.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 7.5 | 97.0 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
| 7.5 | 7.5 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 7.4 | 59.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 7.4 | 22.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 7.4 | 66.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 7.3 | 66.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 7.3 | 29.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 7.3 | 14.7 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 7.3 | 7.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 7.3 | 14.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 7.3 | 29.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 7.3 | 14.5 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 7.3 | 108.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 7.2 | 21.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 7.2 | 14.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 7.2 | 28.9 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 7.2 | 28.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 7.2 | 7.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 7.2 | 71.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 7.2 | 21.5 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 7.2 | 21.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 7.1 | 35.6 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 7.1 | 42.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 7.1 | 14.2 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 7.1 | 49.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 7.1 | 28.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 7.1 | 7.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 7.0 | 14.1 | GO:0048840 | otolith development(GO:0048840) |
| 7.0 | 21.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 7.0 | 105.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 7.0 | 7.0 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 7.0 | 14.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 7.0 | 70.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 7.0 | 21.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 7.0 | 21.0 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 7.0 | 258.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 7.0 | 41.8 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 6.9 | 13.9 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
| 6.9 | 55.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 6.9 | 41.6 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 6.9 | 27.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 6.9 | 13.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 6.9 | 27.7 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 6.9 | 27.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 6.9 | 20.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 6.9 | 55.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 6.9 | 20.7 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 6.9 | 41.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 6.9 | 13.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 6.9 | 289.4 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 6.9 | 82.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 6.9 | 41.3 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
| 6.9 | 75.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 6.9 | 20.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 6.8 | 6.8 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 6.8 | 67.8 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 6.8 | 13.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 6.8 | 60.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 6.8 | 27.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 6.7 | 141.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 6.7 | 20.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 6.7 | 20.1 | GO:1902617 | response to fluoride(GO:1902617) |
| 6.7 | 6.7 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 6.7 | 26.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 6.7 | 20.0 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 6.7 | 39.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 6.6 | 26.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 6.6 | 72.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 6.6 | 33.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 6.6 | 19.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 6.6 | 26.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 6.6 | 85.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 6.5 | 58.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 6.5 | 19.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 6.5 | 6.5 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 6.5 | 6.5 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 6.5 | 142.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 6.5 | 174.7 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 6.4 | 45.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 6.4 | 206.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 6.4 | 19.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 6.4 | 121.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 6.4 | 12.8 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 6.4 | 102.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 6.4 | 152.9 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 6.4 | 69.9 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 6.3 | 12.7 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 6.3 | 44.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 6.3 | 25.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 6.3 | 6.3 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 6.3 | 12.6 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 6.3 | 31.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 6.3 | 6.3 | GO:1990834 | response to odorant(GO:1990834) |
| 6.3 | 18.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 6.3 | 31.3 | GO:0071625 | vocalization behavior(GO:0071625) |
| 6.2 | 56.2 | GO:0060068 | vagina development(GO:0060068) |
| 6.2 | 62.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 6.2 | 31.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 6.2 | 86.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 6.2 | 61.6 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 6.1 | 30.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 6.1 | 24.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 6.1 | 42.9 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 6.1 | 6.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 6.1 | 18.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 6.1 | 12.2 | GO:0072189 | ureter development(GO:0072189) |
| 6.1 | 24.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 6.1 | 48.6 | GO:0061709 | reticulophagy(GO:0061709) |
| 6.1 | 54.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 6.0 | 24.2 | GO:0021781 | glial cell fate commitment(GO:0021781) |
| 6.0 | 18.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 6.0 | 6.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 6.0 | 11.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 6.0 | 23.9 | GO:0033504 | floor plate development(GO:0033504) |
| 6.0 | 11.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 6.0 | 29.8 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 6.0 | 23.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 5.9 | 35.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 5.9 | 23.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 5.9 | 11.8 | GO:2001225 | regulation of chloride transport(GO:2001225) |
| 5.9 | 11.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 5.9 | 53.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 5.9 | 29.5 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 5.9 | 64.7 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 5.9 | 17.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 5.9 | 29.4 | GO:0030070 | insulin processing(GO:0030070) |
| 5.8 | 23.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
| 5.8 | 58.2 | GO:0015871 | choline transport(GO:0015871) |
| 5.8 | 75.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 5.8 | 11.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 5.8 | 17.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 5.8 | 17.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
| 5.8 | 5.8 | GO:0061743 | motor learning(GO:0061743) |
| 5.8 | 17.3 | GO:0009386 | translational attenuation(GO:0009386) |
| 5.8 | 63.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 5.8 | 5.8 | GO:0021794 | thalamus development(GO:0021794) |
| 5.8 | 97.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 5.7 | 51.7 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
| 5.7 | 17.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 5.7 | 40.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 5.7 | 17.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 5.7 | 80.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 5.7 | 17.2 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 5.7 | 17.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 5.7 | 5.7 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 5.7 | 28.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 5.7 | 17.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 5.7 | 22.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 5.7 | 5.7 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 5.7 | 17.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 5.7 | 45.3 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 5.7 | 28.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 5.7 | 34.0 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 5.7 | 84.8 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 5.6 | 16.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 5.6 | 140.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 5.6 | 22.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 5.6 | 44.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 5.6 | 16.8 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 5.6 | 16.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 5.6 | 16.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 5.6 | 27.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 5.6 | 156.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 5.6 | 44.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 5.6 | 22.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 5.5 | 72.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 5.5 | 105.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 5.5 | 148.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 5.5 | 27.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 5.5 | 16.5 | GO:0042756 | drinking behavior(GO:0042756) |
| 5.5 | 54.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 5.5 | 98.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 5.5 | 16.4 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 5.5 | 10.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 5.4 | 32.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 5.4 | 174.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 5.4 | 5.4 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
| 5.4 | 37.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 5.4 | 64.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 5.4 | 5.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
| 5.4 | 21.6 | GO:0007622 | rhythmic behavior(GO:0007622) |
| 5.4 | 226.5 | GO:0019228 | neuronal action potential(GO:0019228) |
| 5.4 | 5.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 5.4 | 10.8 | GO:0060938 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 5.4 | 10.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 5.4 | 128.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 5.4 | 37.5 | GO:0006983 | ER overload response(GO:0006983) |
| 5.3 | 26.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 5.3 | 26.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 5.3 | 21.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 5.3 | 31.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 5.3 | 10.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 5.3 | 15.9 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 5.3 | 63.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 5.3 | 5.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 5.2 | 26.2 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 5.2 | 20.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 5.2 | 15.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 5.2 | 15.6 | GO:0036292 | DNA rewinding(GO:0036292) |
| 5.2 | 46.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 5.2 | 5.2 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 5.2 | 26.0 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
| 5.2 | 20.8 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 5.2 | 5.2 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 5.2 | 15.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 5.2 | 20.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 5.2 | 41.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
| 5.2 | 20.7 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 5.1 | 92.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 5.1 | 20.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 5.1 | 10.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 5.1 | 82.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 5.1 | 15.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 5.1 | 56.2 | GO:0032060 | bleb assembly(GO:0032060) |
| 5.1 | 30.6 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 5.1 | 56.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 5.1 | 45.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 5.1 | 285.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
| 5.1 | 15.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 5.1 | 10.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
| 5.1 | 136.9 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 5.1 | 10.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 5.1 | 45.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 5.1 | 86.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 5.0 | 15.1 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 5.0 | 5.0 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
| 5.0 | 20.2 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 5.0 | 5.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 5.0 | 15.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 5.0 | 15.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 5.0 | 10.0 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
| 5.0 | 135.2 | GO:0035640 | exploration behavior(GO:0035640) |
| 5.0 | 30.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 5.0 | 35.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 5.0 | 5.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 4.9 | 24.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 4.9 | 34.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 4.9 | 19.7 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 4.9 | 4.9 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 4.9 | 4.9 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 4.9 | 34.0 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
| 4.8 | 14.5 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 4.8 | 9.7 | GO:1990637 | response to prolactin(GO:1990637) |
| 4.8 | 19.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 4.8 | 19.2 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) |
| 4.8 | 38.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 4.8 | 4.8 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 4.8 | 43.0 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 4.8 | 14.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 4.8 | 9.5 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 4.8 | 19.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 4.8 | 80.8 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 4.7 | 33.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 4.7 | 23.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 4.7 | 4.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 4.7 | 14.1 | GO:0061163 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 4.7 | 28.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 4.7 | 28.1 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 4.7 | 28.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 4.7 | 9.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 4.7 | 18.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 4.7 | 4.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 4.7 | 23.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 4.6 | 69.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 4.6 | 116.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 4.6 | 9.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 4.6 | 78.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 4.6 | 23.2 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
| 4.6 | 27.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 4.6 | 50.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 4.6 | 9.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 4.6 | 13.8 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 4.6 | 18.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 4.6 | 50.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 4.6 | 4.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 4.6 | 4.6 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 4.6 | 9.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 4.6 | 13.7 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 4.5 | 9.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 4.5 | 58.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 4.5 | 13.6 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 4.5 | 13.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 4.5 | 13.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 4.5 | 130.1 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 4.5 | 17.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 4.5 | 8.9 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 4.5 | 13.4 | GO:1903537 | meiotic spindle elongation(GO:0051232) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 4.5 | 4.5 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 4.4 | 4.4 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 4.4 | 8.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 4.4 | 269.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 4.4 | 22.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 4.4 | 70.3 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 4.4 | 8.8 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 4.4 | 48.1 | GO:0035878 | nail development(GO:0035878) |
| 4.4 | 26.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 4.3 | 26.0 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 4.3 | 34.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 4.3 | 4.3 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 4.3 | 38.9 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 4.3 | 4.3 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
| 4.3 | 21.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 4.3 | 8.6 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 4.3 | 167.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 4.3 | 77.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 4.3 | 21.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 4.3 | 4.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 4.3 | 17.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 4.3 | 17.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
| 4.3 | 17.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 4.3 | 59.5 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 4.2 | 229.1 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 4.2 | 8.5 | GO:2001186 | regulation of T cell antigen processing and presentation(GO:0002625) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 4.2 | 33.8 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
| 4.2 | 16.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 4.2 | 29.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 4.2 | 12.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 4.2 | 50.3 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 4.2 | 29.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 4.2 | 4.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 4.2 | 41.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
| 4.2 | 20.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 4.2 | 8.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 4.1 | 70.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 4.1 | 12.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 4.1 | 227.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 4.1 | 12.4 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 4.1 | 4.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 4.1 | 12.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 4.1 | 24.7 | GO:0097186 | amelogenesis(GO:0097186) |
| 4.1 | 16.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 4.1 | 16.3 | GO:0072311 | glomerular epithelial cell differentiation(GO:0072311) |
| 4.1 | 8.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 4.1 | 40.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 4.1 | 12.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 4.1 | 8.1 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 4.0 | 8.0 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 4.0 | 4.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 4.0 | 12.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 4.0 | 12.0 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 4.0 | 12.0 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 4.0 | 51.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 4.0 | 19.9 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 4.0 | 35.9 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 4.0 | 19.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 4.0 | 4.0 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 4.0 | 15.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 4.0 | 59.6 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 4.0 | 15.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 4.0 | 11.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 3.9 | 3.9 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 3.9 | 3.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 3.9 | 35.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 3.9 | 3.9 | GO:0010543 | regulation of platelet activation(GO:0010543) |
| 3.9 | 3.9 | GO:0002118 | aggressive behavior(GO:0002118) |
| 3.9 | 11.6 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 3.9 | 42.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 3.9 | 54.2 | GO:0008038 | neuron recognition(GO:0008038) |
| 3.9 | 15.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 3.9 | 11.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 3.9 | 27.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 3.9 | 30.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 3.9 | 7.7 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 3.9 | 38.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 3.9 | 11.6 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 3.8 | 34.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 3.8 | 42.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 3.8 | 7.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 3.8 | 7.7 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 3.8 | 7.7 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 3.8 | 19.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 3.8 | 80.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 3.8 | 7.6 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 3.8 | 22.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 3.8 | 7.6 | GO:0007538 | primary sex determination(GO:0007538) |
| 3.8 | 3.8 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 3.8 | 18.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 3.8 | 11.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 3.8 | 30.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 3.7 | 22.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 3.7 | 11.2 | GO:0048102 | autophagic cell death(GO:0048102) |
| 3.7 | 7.4 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
| 3.7 | 7.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 3.7 | 22.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 3.7 | 7.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 3.7 | 26.0 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
| 3.7 | 11.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 3.7 | 3.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 3.7 | 14.8 | GO:0097484 | dendrite extension(GO:0097484) |
| 3.7 | 199.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 3.7 | 3.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 3.6 | 10.9 | GO:0044804 | nucleophagy(GO:0044804) |
| 3.6 | 18.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 3.6 | 10.9 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 3.6 | 18.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 3.6 | 3.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 3.6 | 83.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 3.6 | 32.6 | GO:0015886 | heme transport(GO:0015886) |
| 3.6 | 3.6 | GO:0060290 | transdifferentiation(GO:0060290) |
| 3.6 | 7.2 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 3.6 | 3.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 3.6 | 25.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 3.6 | 10.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 3.6 | 32.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 3.6 | 7.1 | GO:0009750 | response to fructose(GO:0009750) |
| 3.6 | 3.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 3.6 | 21.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 3.6 | 10.7 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 3.6 | 3.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 3.6 | 17.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 3.5 | 14.2 | GO:0045176 | apical protein localization(GO:0045176) |
| 3.5 | 31.9 | GO:0021854 | hypothalamus development(GO:0021854) |
| 3.5 | 10.6 | GO:0072017 | distal tubule development(GO:0072017) |
| 3.5 | 21.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 3.5 | 45.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 3.5 | 10.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 3.5 | 7.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 3.5 | 10.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 3.5 | 38.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 3.5 | 10.4 | GO:0010934 | macrophage cytokine production(GO:0010934) |
| 3.5 | 24.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 3.5 | 145.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 3.4 | 6.9 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
| 3.4 | 3.4 | GO:0035801 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) embryonic heart tube left/right pattern formation(GO:0060971) |
| 3.4 | 3.4 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 3.4 | 65.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 3.4 | 20.5 | GO:0034201 | response to oleic acid(GO:0034201) |
| 3.4 | 17.1 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 3.4 | 27.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 3.4 | 44.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 3.4 | 20.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 3.4 | 13.6 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 3.4 | 81.4 | GO:0014850 | response to muscle activity(GO:0014850) |
| 3.4 | 20.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 3.4 | 6.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 3.4 | 3.4 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 3.3 | 26.8 | GO:0030539 | male genitalia development(GO:0030539) |
| 3.3 | 53.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 3.3 | 13.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 3.3 | 6.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 3.3 | 3.3 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 3.3 | 16.6 | GO:0007512 | adult heart development(GO:0007512) |
| 3.3 | 460.2 | GO:0006813 | potassium ion transport(GO:0006813) |
| 3.3 | 9.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 3.3 | 6.6 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 3.3 | 26.4 | GO:0070633 | transepithelial transport(GO:0070633) |
| 3.3 | 42.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 3.3 | 19.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 3.3 | 52.2 | GO:0097576 | vacuole fusion(GO:0097576) |
| 3.3 | 16.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 3.3 | 42.3 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 3.3 | 22.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 3.3 | 52.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 3.2 | 25.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 3.2 | 3.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 3.2 | 12.9 | GO:2000864 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 3.2 | 128.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 3.2 | 3.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 3.2 | 9.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 3.2 | 9.6 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 3.2 | 31.8 | GO:0021988 | olfactory lobe development(GO:0021988) |
| 3.1 | 3.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 3.1 | 12.5 | GO:0015705 | iodide transport(GO:0015705) |
| 3.1 | 49.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 3.1 | 71.4 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 3.1 | 21.6 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 3.1 | 3.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 3.1 | 6.1 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 3.1 | 18.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 3.0 | 12.2 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 3.0 | 3.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 3.0 | 3.0 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 3.0 | 30.2 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 3.0 | 15.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) regulation of endothelial tube morphogenesis(GO:1901509) |
| 3.0 | 12.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 3.0 | 12.0 | GO:0090009 | primitive streak formation(GO:0090009) |
| 3.0 | 3.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 3.0 | 11.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 3.0 | 20.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 3.0 | 38.6 | GO:0007398 | ectoderm development(GO:0007398) |
| 3.0 | 213.1 | GO:0007626 | locomotory behavior(GO:0007626) |
| 2.9 | 44.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 2.9 | 5.9 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 2.9 | 5.9 | GO:2000520 | positive regulation of mononuclear cell migration(GO:0071677) regulation of immunological synapse formation(GO:2000520) negative regulation of immunological synapse formation(GO:2000521) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
| 2.9 | 2.9 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
| 2.9 | 14.6 | GO:0071711 | basement membrane organization(GO:0071711) |
| 2.9 | 8.8 | GO:0015847 | putrescine transport(GO:0015847) |
| 2.9 | 20.5 | GO:0007616 | long-term memory(GO:0007616) |
| 2.9 | 20.4 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 2.9 | 8.8 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 2.9 | 204.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 2.9 | 5.8 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 2.9 | 115.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 2.9 | 2.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 2.9 | 14.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 2.8 | 8.5 | GO:0034371 | chylomicron remodeling(GO:0034371) |
| 2.8 | 5.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 2.8 | 195.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 2.8 | 56.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 2.8 | 16.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 2.8 | 84.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 2.8 | 5.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 2.8 | 5.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 2.8 | 13.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 2.8 | 8.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 2.8 | 13.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 2.8 | 13.8 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 2.8 | 47.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 2.8 | 8.3 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) |
| 2.8 | 19.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 2.7 | 11.0 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 2.7 | 35.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 2.7 | 10.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 2.7 | 10.8 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 2.7 | 27.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 2.7 | 8.1 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 2.7 | 16.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 2.7 | 16.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 2.7 | 10.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 2.7 | 2.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 2.7 | 5.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 2.7 | 5.3 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 2.6 | 18.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 2.6 | 13.2 | GO:0021544 | subpallium development(GO:0021544) |
| 2.6 | 18.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
| 2.6 | 7.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 2.6 | 2.6 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 2.6 | 7.9 | GO:0019046 | release from viral latency(GO:0019046) |
| 2.6 | 13.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 2.6 | 10.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 2.6 | 7.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 2.6 | 5.2 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
| 2.6 | 10.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 2.6 | 10.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.6 | 10.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 2.6 | 10.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 2.6 | 12.8 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 2.6 | 20.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 2.6 | 2.6 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
| 2.5 | 10.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 2.5 | 127.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 2.5 | 10.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 2.5 | 22.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 2.5 | 7.5 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 2.5 | 12.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 2.5 | 5.0 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 2.5 | 60.3 | GO:0007416 | synapse assembly(GO:0007416) |
| 2.5 | 2.5 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 2.5 | 40.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 2.5 | 2.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 2.5 | 5.0 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 2.5 | 106.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 2.5 | 17.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 2.5 | 103.6 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
| 2.5 | 7.4 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 2.4 | 26.8 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 2.4 | 9.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 2.4 | 4.8 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 2.4 | 4.8 | GO:0015872 | dopamine transport(GO:0015872) |
| 2.4 | 4.8 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 2.4 | 12.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 2.4 | 26.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 2.4 | 7.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 2.4 | 7.1 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 2.4 | 4.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 2.4 | 4.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 2.3 | 7.0 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 2.3 | 4.7 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 2.3 | 28.0 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 2.3 | 13.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 2.3 | 27.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 2.3 | 20.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 2.3 | 9.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 2.3 | 9.3 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 2.3 | 16.1 | GO:0042148 | strand invasion(GO:0042148) |
| 2.3 | 2.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 2.3 | 6.9 | GO:0044848 | biological phase(GO:0044848) |
| 2.3 | 11.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 2.3 | 16.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 2.3 | 54.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 2.3 | 2.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 2.3 | 15.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 2.2 | 2.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 2.2 | 2.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 2.2 | 2.2 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 2.2 | 6.7 | GO:0038001 | paracrine signaling(GO:0038001) |
| 2.2 | 11.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 2.2 | 4.5 | GO:0048664 | neuron fate determination(GO:0048664) |
| 2.2 | 13.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 2.2 | 11.1 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 2.2 | 8.8 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 2.2 | 8.8 | GO:0034628 | aspartate metabolic process(GO:0006531) nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 2.2 | 232.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 2.2 | 4.4 | GO:0014002 | astrocyte development(GO:0014002) |
| 2.2 | 58.9 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 2.2 | 10.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 2.2 | 13.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 2.2 | 4.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 2.2 | 30.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 2.1 | 4.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 2.1 | 55.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 2.1 | 10.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 2.1 | 8.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 2.1 | 2.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 2.1 | 2.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 2.1 | 4.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 2.1 | 18.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 2.1 | 6.3 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 2.1 | 20.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 2.1 | 26.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 2.0 | 81.9 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 2.0 | 10.2 | GO:0032456 | endocytic recycling(GO:0032456) |
| 2.0 | 18.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 2.0 | 4.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 2.0 | 2.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 2.0 | 6.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 2.0 | 8.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 2.0 | 4.0 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 2.0 | 4.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
| 2.0 | 13.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 2.0 | 5.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 2.0 | 3.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 2.0 | 3.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 1.9 | 59.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 1.9 | 1.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 1.9 | 1.9 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 1.9 | 15.0 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 1.9 | 13.0 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
| 1.9 | 13.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 1.9 | 7.4 | GO:0001555 | oocyte growth(GO:0001555) |
| 1.8 | 3.7 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
| 1.8 | 21.9 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 1.8 | 1.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 1.8 | 27.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 1.8 | 3.6 | GO:0060384 | innervation(GO:0060384) |
| 1.8 | 9.0 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 1.8 | 5.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 1.8 | 8.9 | GO:0031018 | endocrine pancreas development(GO:0031018) |
| 1.8 | 1.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.8 | 1.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 1.7 | 8.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.7 | 1.7 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) mast cell proliferation(GO:0070662) |
| 1.7 | 15.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 1.7 | 1.7 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.7 | 3.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
| 1.7 | 10.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 1.7 | 8.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 1.7 | 17.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 1.7 | 29.2 | GO:0046323 | glucose import(GO:0046323) |
| 1.7 | 8.5 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 1.7 | 11.9 | GO:0001947 | heart looping(GO:0001947) |
| 1.7 | 1.7 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 1.7 | 5.1 | GO:1990403 | embryonic brain development(GO:1990403) |
| 1.7 | 1.7 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
| 1.7 | 6.8 | GO:0001508 | action potential(GO:0001508) |
| 1.7 | 15.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 1.7 | 1.7 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 1.7 | 11.8 | GO:0090042 | tubulin deacetylation(GO:0090042) |
| 1.7 | 42.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 1.7 | 13.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 1.7 | 23.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 1.7 | 3.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.6 | 9.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 1.6 | 4.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 1.6 | 9.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 1.6 | 4.7 | GO:0030578 | PML body organization(GO:0030578) |
| 1.6 | 7.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 1.6 | 17.2 | GO:0036065 | fucosylation(GO:0036065) |
| 1.6 | 4.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 1.5 | 10.7 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 1.5 | 4.6 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 1.5 | 4.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 1.5 | 4.5 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 1.5 | 4.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 1.5 | 3.0 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 1.5 | 17.6 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 1.5 | 32.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 1.5 | 4.4 | GO:0051414 | response to cortisol(GO:0051414) |
| 1.5 | 4.4 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 1.5 | 8.7 | GO:0002784 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.5 | 7.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.4 | 8.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 1.4 | 4.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactosylceramide catabolic process(GO:0006683) |
| 1.4 | 7.1 | GO:0045007 | depurination(GO:0045007) |
| 1.4 | 5.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 1.4 | 11.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
| 1.4 | 5.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 1.4 | 1.4 | GO:0051133 | regulation of NK T cell activation(GO:0051133) |
| 1.4 | 16.4 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 1.4 | 5.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 1.4 | 2.7 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 1.4 | 54.3 | GO:0007041 | lysosomal transport(GO:0007041) |
| 1.4 | 9.5 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 1.4 | 28.4 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 1.3 | 5.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 1.3 | 2.7 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 1.3 | 6.6 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
| 1.3 | 5.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 1.3 | 9.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 1.3 | 7.9 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 1.3 | 2.6 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 1.3 | 92.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 1.3 | 28.5 | GO:0001706 | endoderm formation(GO:0001706) |
| 1.3 | 7.8 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 1.3 | 1.3 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 1.3 | 3.9 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 1.3 | 3.9 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 1.3 | 3.8 | GO:1904064 | positive regulation of cation transmembrane transport(GO:1904064) |
| 1.3 | 5.1 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
| 1.3 | 17.6 | GO:0014047 | glutamate secretion(GO:0014047) |
| 1.3 | 13.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 1.3 | 10.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 1.3 | 23.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 1.3 | 10.0 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
| 1.3 | 5.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 1.2 | 1.2 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
| 1.2 | 49.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 1.2 | 26.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 1.2 | 14.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 1.2 | 22.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 1.2 | 4.9 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 1.2 | 7.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 1.2 | 31.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 1.2 | 27.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 1.2 | 1.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 1.2 | 10.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 1.2 | 27.0 | GO:0097502 | mannosylation(GO:0097502) |
| 1.2 | 25.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 1.2 | 1.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 1.2 | 10.4 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
| 1.2 | 2.3 | GO:0003156 | regulation of organ formation(GO:0003156) |
| 1.2 | 11.5 | GO:0031033 | myosin filament organization(GO:0031033) |
| 1.1 | 3.4 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 1.1 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.1 | 11.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 1.1 | 2.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 1.1 | 17.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 1.1 | 3.3 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 1.1 | 1.1 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 1.1 | 1.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.1 | 4.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 1.1 | 5.4 | GO:0048278 | vesicle docking(GO:0048278) |
| 1.1 | 2.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 1.1 | 4.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 1.1 | 102.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 1.1 | 7.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.1 | 6.4 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 1.1 | 1.1 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 1.1 | 1.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.1 | 2.1 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
| 1.0 | 2.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 1.0 | 4.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 1.0 | 17.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 1.0 | 10.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 1.0 | 18.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 1.0 | 22.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.0 | 22.2 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
| 1.0 | 8.0 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
| 1.0 | 37.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 1.0 | 7.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 1.0 | 3.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.0 | 3.0 | GO:0042426 | choline catabolic process(GO:0042426) |
| 1.0 | 2.9 | GO:0060087 | negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
| 1.0 | 3.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 1.0 | 3.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 1.0 | 14.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 1.0 | 2.9 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 1.0 | 19.1 | GO:0031167 | rRNA methylation(GO:0031167) |
| 1.0 | 1.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 1.0 | 2.9 | GO:1903565 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.9 | 0.9 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.9 | 0.9 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.9 | 5.6 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.9 | 2.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.9 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
| 0.9 | 0.9 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.9 | 4.6 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.9 | 9.3 | GO:0044117 | growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 0.9 | 2.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.9 | 4.6 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.9 | 1.8 | GO:0030047 | actin modification(GO:0030047) |
| 0.9 | 2.7 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
| 0.9 | 107.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.9 | 5.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.9 | 9.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.9 | 0.9 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
| 0.9 | 2.6 | GO:1990918 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.9 | 2.6 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.9 | 5.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.9 | 4.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.9 | 10.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.9 | 0.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.9 | 2.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.9 | 2.6 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.8 | 3.4 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.8 | 8.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.8 | 2.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.8 | 11.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.8 | 9.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.8 | 8.0 | GO:0097435 | fibril organization(GO:0097435) |
| 0.8 | 4.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.8 | 28.0 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.8 | 2.4 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 0.8 | 2.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.8 | 2.4 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.8 | 14.2 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.8 | 7.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.8 | 9.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.8 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.7 | 9.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.7 | 2.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.7 | 2.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.7 | 1.5 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.7 | 4.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.7 | 2.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.7 | 1.5 | GO:0032616 | interleukin-13 production(GO:0032616) |
| 0.7 | 7.3 | GO:0034694 | response to prostaglandin(GO:0034694) |
| 0.7 | 1.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.7 | 1.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.7 | 4.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.7 | 7.9 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.7 | 2.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.7 | 4.9 | GO:0034969 | histone arginine methylation(GO:0034969) |
| 0.7 | 19.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.7 | 0.7 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.7 | 1.4 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.7 | 2.1 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 0.7 | 3.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.7 | 68.0 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
| 0.7 | 14.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
| 0.7 | 24.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.7 | 30.5 | GO:0007586 | digestion(GO:0007586) |
| 0.7 | 1.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.7 | 3.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.6 | 20.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.6 | 10.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.6 | 3.1 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.6 | 1.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.6 | 6.2 | GO:0007632 | visual behavior(GO:0007632) |
| 0.6 | 2.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.6 | 18.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.6 | 3.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.6 | 1.2 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.6 | 1.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.6 | 1.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.6 | 6.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.6 | 4.0 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.6 | 6.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.6 | 3.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.5 | 1.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.5 | 3.2 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.5 | 9.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
| 0.5 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.5 | 1.1 | GO:0015824 | proline transport(GO:0015824) |
| 0.5 | 6.3 | GO:0006833 | water transport(GO:0006833) |
| 0.5 | 2.6 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.5 | 1.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.5 | 5.2 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.5 | 0.5 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
| 0.5 | 1.5 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.5 | 1.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.5 | 2.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.5 | 0.5 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.5 | 1.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.5 | 2.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.5 | 1.0 | GO:0007320 | insemination(GO:0007320) |
| 0.5 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.5 | 3.2 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.5 | 5.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.5 | 1.8 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
| 0.5 | 2.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.4 | 2.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.4 | 0.9 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 | 4.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.4 | 3.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 | 153.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.4 | 1.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 | 3.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.4 | 2.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.4 | 2.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.4 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.4 | 8.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.4 | 0.8 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.4 | 1.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.4 | 2.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.4 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.4 | 1.1 | GO:0007135 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) |
| 0.3 | 1.7 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 | 1.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.3 | 1.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.3 | 7.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.3 | 1.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.3 | 2.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
| 0.3 | 0.3 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 0.3 | 0.6 | GO:0002903 | regulation of B cell apoptotic process(GO:0002902) negative regulation of B cell apoptotic process(GO:0002903) |
| 0.3 | 2.6 | GO:0015747 | urate transport(GO:0015747) |
| 0.3 | 0.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.3 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.3 | 6.8 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.3 | 1.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.3 | 18.0 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.3 | 1.7 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.3 | 0.8 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.3 | 1.6 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 | 2.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.2 | 1.7 | GO:0072338 | cellular lactam metabolic process(GO:0072338) |
| 0.2 | 3.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.2 | 4.0 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
| 0.2 | 0.2 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.2 | 2.3 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.2 | 1.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 0.4 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
| 0.2 | 0.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.2 | 0.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 1.0 | GO:0048806 | genitalia development(GO:0048806) |
| 0.2 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.2 | 0.4 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.2 | 0.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.2 | 0.5 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 0.3 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.2 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.1 | 12.4 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
| 0.1 | 1.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 11.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.1 | 1.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.1 | 0.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 2.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 0.1 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 | 0.3 | GO:0032324 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 2.4 | GO:0097485 | neuron projection guidance(GO:0097485) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 | 0.3 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 53.0 | 211.9 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 49.9 | 199.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 44.3 | 132.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 43.0 | 257.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 31.8 | 31.8 | GO:0019034 | viral replication complex(GO:0019034) |
| 31.5 | 94.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 26.7 | 133.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 25.9 | 103.6 | GO:0070695 | FHF complex(GO:0070695) |
| 25.5 | 229.4 | GO:0044327 | dendritic spine head(GO:0044327) |
| 25.5 | 152.8 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 24.6 | 98.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 23.0 | 46.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 22.4 | 67.1 | GO:0048788 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 22.1 | 66.3 | GO:0060987 | lipid tube(GO:0060987) |
| 19.6 | 58.7 | GO:0034455 | t-UTP complex(GO:0034455) |
| 19.5 | 19.5 | GO:0005883 | neurofilament(GO:0005883) |
| 19.3 | 38.7 | GO:0014802 | terminal cisterna(GO:0014802) |
| 18.7 | 112.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 18.7 | 411.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 18.7 | 56.0 | GO:0016938 | kinesin I complex(GO:0016938) |
| 18.1 | 90.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 18.0 | 107.8 | GO:0045298 | tubulin complex(GO:0045298) |
| 17.9 | 89.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 17.2 | 344.8 | GO:0033270 | paranode region of axon(GO:0033270) |
| 16.5 | 49.5 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 16.0 | 63.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 15.9 | 47.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 15.8 | 252.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 15.7 | 15.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 15.6 | 77.9 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 15.5 | 139.8 | GO:0033391 | chromatoid body(GO:0033391) |
| 15.4 | 200.3 | GO:0043194 | axon initial segment(GO:0043194) |
| 14.6 | 58.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 14.5 | 43.4 | GO:0043293 | apoptosome(GO:0043293) |
| 14.4 | 129.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 14.0 | 826.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 13.9 | 83.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 13.4 | 201.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 13.4 | 107.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 13.3 | 40.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 13.3 | 39.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 13.3 | 119.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 13.0 | 77.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 12.8 | 25.7 | GO:0001939 | female pronucleus(GO:0001939) |
| 12.8 | 38.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 12.7 | 393.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 12.6 | 113.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 11.9 | 59.7 | GO:0031673 | H zone(GO:0031673) |
| 11.8 | 23.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 11.7 | 163.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 11.5 | 172.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 11.4 | 34.3 | GO:0044609 | DBIRD complex(GO:0044609) |
| 11.4 | 57.1 | GO:0032449 | CBM complex(GO:0032449) |
| 11.4 | 113.5 | GO:0042583 | chromaffin granule(GO:0042583) |
| 11.3 | 34.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 11.2 | 55.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 11.1 | 33.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 11.0 | 88.0 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 11.0 | 33.0 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 10.8 | 107.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 10.7 | 64.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 10.7 | 53.6 | GO:0045160 | myosin I complex(GO:0045160) |
| 10.5 | 42.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 10.2 | 71.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 10.2 | 10.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 10.2 | 71.5 | GO:1990130 | Iml1 complex(GO:1990130) |
| 10.1 | 60.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 10.1 | 20.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 9.9 | 19.9 | GO:0044308 | axonal spine(GO:0044308) |
| 9.9 | 89.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 9.7 | 106.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 9.6 | 57.8 | GO:0033269 | internode region of axon(GO:0033269) |
| 9.6 | 134.8 | GO:0043083 | synaptic cleft(GO:0043083) |
| 9.6 | 28.7 | GO:0055028 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
| 9.5 | 47.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 9.5 | 57.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 9.4 | 66.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 9.1 | 54.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 9.1 | 145.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 9.1 | 36.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 9.0 | 215.2 | GO:0044295 | axonal growth cone(GO:0044295) |
| 8.9 | 160.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 8.9 | 80.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 8.9 | 230.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 8.8 | 672.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 8.8 | 35.0 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 8.7 | 542.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 8.6 | 164.3 | GO:0097386 | glial cell projection(GO:0097386) |
| 8.6 | 68.9 | GO:0043203 | axon hillock(GO:0043203) |
| 8.6 | 94.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 8.6 | 8.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 8.4 | 25.2 | GO:0036398 | TCR signalosome(GO:0036398) |
| 8.4 | 134.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 8.3 | 8.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 8.3 | 33.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 8.3 | 24.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 8.3 | 8.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 8.2 | 24.5 | GO:0071439 | clathrin complex(GO:0071439) |
| 8.1 | 347.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 7.9 | 23.8 | GO:0098536 | deuterosome(GO:0098536) |
| 7.7 | 100.0 | GO:0031045 | dense core granule(GO:0031045) |
| 7.7 | 352.7 | GO:0097546 | ciliary base(GO:0097546) |
| 7.5 | 60.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 7.5 | 22.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 7.3 | 29.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 7.3 | 65.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 7.3 | 21.8 | GO:0097229 | sperm end piece(GO:0097229) |
| 7.2 | 65.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 7.2 | 100.9 | GO:0032590 | dendrite membrane(GO:0032590) |
| 7.2 | 100.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 7.2 | 28.6 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 7.1 | 85.1 | GO:0016013 | syntrophin complex(GO:0016013) |
| 7.0 | 224.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 7.0 | 70.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 6.9 | 34.7 | GO:0070847 | core mediator complex(GO:0070847) |
| 6.8 | 27.2 | GO:1990879 | CST complex(GO:1990879) |
| 6.8 | 20.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 6.8 | 13.5 | GO:0034657 | GID complex(GO:0034657) |
| 6.7 | 13.3 | GO:0032426 | stereocilium tip(GO:0032426) |
| 6.7 | 33.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 6.6 | 205.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 6.6 | 457.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 6.6 | 119.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 6.6 | 52.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 6.6 | 111.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 6.6 | 19.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 6.5 | 19.4 | GO:0034706 | sodium channel complex(GO:0034706) |
| 6.5 | 64.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 6.5 | 19.4 | GO:0097443 | sorting endosome(GO:0097443) |
| 6.4 | 83.7 | GO:0097433 | dense body(GO:0097433) |
| 6.4 | 83.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 6.3 | 742.3 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 6.3 | 31.7 | GO:0033010 | paranodal junction(GO:0033010) |
| 6.3 | 37.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 6.3 | 44.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 6.3 | 69.4 | GO:0005955 | calcineurin complex(GO:0005955) |
| 6.2 | 25.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 6.2 | 37.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 6.2 | 24.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 6.1 | 67.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 6.1 | 24.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 6.1 | 429.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 6.0 | 24.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 5.8 | 69.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 5.8 | 5.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 5.7 | 11.5 | GO:0071546 | pi-body(GO:0071546) |
| 5.7 | 280.6 | GO:0043198 | dendritic shaft(GO:0043198) |
| 5.7 | 11.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 5.7 | 56.8 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 5.7 | 39.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 5.6 | 67.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 5.6 | 33.4 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 5.4 | 65.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 5.4 | 10.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 5.4 | 1258.5 | GO:0060076 | excitatory synapse(GO:0060076) |
| 5.4 | 383.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 5.4 | 64.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 5.3 | 37.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 5.3 | 21.2 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 5.2 | 10.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 5.2 | 67.8 | GO:0030478 | actin cap(GO:0030478) |
| 5.2 | 46.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 5.2 | 15.6 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 5.2 | 56.8 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 5.1 | 40.8 | GO:0072487 | MSL complex(GO:0072487) |
| 5.1 | 50.8 | GO:0008091 | spectrin(GO:0008091) |
| 5.0 | 196.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 5.0 | 10.1 | GO:0016939 | kinesin II complex(GO:0016939) |
| 5.0 | 15.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 5.0 | 15.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 5.0 | 164.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 4.9 | 14.6 | GO:0031251 | PAN complex(GO:0031251) |
| 4.8 | 842.9 | GO:0098793 | presynapse(GO:0098793) |
| 4.8 | 19.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 4.7 | 18.9 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 4.7 | 28.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 4.7 | 4.7 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 4.6 | 18.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 4.6 | 308.2 | GO:0005581 | collagen trimer(GO:0005581) |
| 4.6 | 23.0 | GO:0097513 | myosin II filament(GO:0097513) |
| 4.6 | 109.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 4.6 | 27.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 4.5 | 144.8 | GO:0060170 | ciliary membrane(GO:0060170) |
| 4.4 | 13.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 4.4 | 492.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 4.4 | 17.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 4.3 | 17.4 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 4.3 | 21.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 4.3 | 21.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 4.3 | 21.4 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 4.3 | 327.9 | GO:0036064 | ciliary basal body(GO:0036064) |
| 4.2 | 20.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 4.2 | 41.5 | GO:0045180 | basal cortex(GO:0045180) |
| 4.1 | 256.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 4.1 | 16.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 4.1 | 8.2 | GO:1990393 | 3M complex(GO:1990393) |
| 4.1 | 73.1 | GO:0005922 | connexon complex(GO:0005922) |
| 4.0 | 16.2 | GO:0035363 | histone locus body(GO:0035363) |
| 4.0 | 28.2 | GO:1990745 | EARP complex(GO:1990745) |
| 3.9 | 54.4 | GO:0000800 | lateral element(GO:0000800) |
| 3.8 | 7.6 | GO:0000805 | X chromosome(GO:0000805) |
| 3.7 | 14.9 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 3.7 | 3.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 3.7 | 128.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 3.6 | 40.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 3.6 | 39.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 3.6 | 21.6 | GO:0031527 | filopodium membrane(GO:0031527) |
| 3.6 | 17.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 3.5 | 77.5 | GO:0042627 | chylomicron(GO:0042627) |
| 3.5 | 945.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 3.4 | 34.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 3.4 | 291.9 | GO:0043204 | perikaryon(GO:0043204) |
| 3.4 | 10.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 3.4 | 16.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 3.4 | 70.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 3.3 | 10.0 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 3.3 | 23.3 | GO:0042599 | lamellar body(GO:0042599) |
| 3.2 | 19.5 | GO:0001940 | male pronucleus(GO:0001940) |
| 3.2 | 9.7 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 3.2 | 19.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 3.2 | 12.7 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
| 3.1 | 40.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 3.1 | 9.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 3.0 | 69.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
| 3.0 | 27.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 3.0 | 44.8 | GO:0097225 | sperm midpiece(GO:0097225) |
| 3.0 | 29.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 2.9 | 99.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 2.9 | 114.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 2.8 | 238.4 | GO:0005814 | centriole(GO:0005814) |
| 2.8 | 90.6 | GO:0016235 | aggresome(GO:0016235) |
| 2.8 | 5.7 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 2.8 | 5.6 | GO:0043291 | RAVE complex(GO:0043291) |
| 2.8 | 608.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 2.7 | 131.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 2.7 | 16.3 | GO:0032009 | early phagosome(GO:0032009) |
| 2.7 | 16.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 2.6 | 23.7 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 2.6 | 13.0 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 2.5 | 22.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 2.5 | 10.0 | GO:0060091 | kinocilium(GO:0060091) |
| 2.5 | 15.0 | GO:0097440 | apical dendrite(GO:0097440) |
| 2.5 | 7.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 2.5 | 64.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 2.4 | 2.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 2.4 | 28.9 | GO:0000145 | exocyst(GO:0000145) |
| 2.4 | 16.8 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 2.4 | 23.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 2.4 | 35.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 2.4 | 23.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 2.3 | 20.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 2.3 | 329.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 2.3 | 13.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 2.3 | 54.9 | GO:0030057 | desmosome(GO:0030057) |
| 2.3 | 222.5 | GO:0030426 | growth cone(GO:0030426) |
| 2.2 | 4.5 | GO:0031905 | early endosome lumen(GO:0031905) |
| 2.2 | 2.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 2.2 | 15.2 | GO:0036157 | outer dynein arm(GO:0036157) |
| 2.2 | 15.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 2.2 | 6.5 | GO:0032116 | SMC loading complex(GO:0032116) |
| 2.2 | 51.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 2.1 | 113.0 | GO:0055037 | recycling endosome(GO:0055037) |
| 2.1 | 10.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 2.0 | 55.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 2.0 | 33.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 2.0 | 33.6 | GO:0031082 | BLOC complex(GO:0031082) |
| 2.0 | 3.9 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 2.0 | 7.8 | GO:0002177 | manchette(GO:0002177) |
| 2.0 | 9.8 | GO:0030427 | site of polarized growth(GO:0030427) |
| 1.9 | 1.9 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 1.9 | 46.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 1.9 | 9.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 1.9 | 86.3 | GO:0005902 | microvillus(GO:0005902) |
| 1.8 | 7.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 1.8 | 5.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.8 | 19.8 | GO:0030870 | Mre11 complex(GO:0030870) |
| 1.8 | 7.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 1.8 | 5.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 1.7 | 49.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 1.7 | 218.0 | GO:0043025 | neuronal cell body(GO:0043025) |
| 1.7 | 50.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 1.7 | 8.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 1.7 | 205.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 1.7 | 10.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 1.7 | 360.9 | GO:0043235 | receptor complex(GO:0043235) |
| 1.7 | 13.3 | GO:0044447 | axoneme part(GO:0044447) |
| 1.7 | 18.2 | GO:0000974 | Prp19 complex(GO:0000974) |
| 1.6 | 6214.0 | GO:0016021 | integral component of membrane(GO:0016021) |
| 1.6 | 9.7 | GO:0070545 | PeBoW complex(GO:0070545) |
| 1.6 | 11.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 1.5 | 4.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 1.5 | 3.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 1.5 | 11.8 | GO:0071437 | invadopodium(GO:0071437) |
| 1.5 | 4.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 1.5 | 1.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 1.5 | 16.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 1.4 | 7.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 1.4 | 22.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 1.3 | 14.4 | GO:0000242 | pericentriolar material(GO:0000242) |
| 1.3 | 35.7 | GO:0016459 | myosin complex(GO:0016459) |
| 1.3 | 5.1 | GO:0001739 | sex chromatin(GO:0001739) |
| 1.2 | 17.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 1.2 | 54.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 1.2 | 2.4 | GO:0036038 | MKS complex(GO:0036038) |
| 1.2 | 1.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 1.2 | 4.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 1.1 | 2.3 | GO:0042588 | zymogen granule(GO:0042588) |
| 1.1 | 3.3 | GO:0033267 | axon part(GO:0033267) |
| 1.1 | 72.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 1.0 | 6.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 1.0 | 1.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.0 | 3.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.9 | 8.9 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.8 | 48.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.8 | 4.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.8 | 5.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.8 | 11.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.8 | 1.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.8 | 10.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.7 | 2.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.7 | 10.6 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.7 | 2.0 | GO:0000801 | central element(GO:0000801) |
| 0.6 | 46.9 | GO:0005770 | late endosome(GO:0005770) |
| 0.6 | 3.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.6 | 2.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.5 | 2.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.5 | 6.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.4 | 5.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.3 | 1.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 0.6 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.3 | 3.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 9.4 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.3 | 3.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.2 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.2 | 1.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 1.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.1 | 0.1 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 0.1 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.1 | 0.8 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.1 | 3.3 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 84.6 | 338.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 53.8 | 269.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 53.0 | 211.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 50.2 | 200.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 43.6 | 174.5 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 41.4 | 124.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 34.3 | 137.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 33.8 | 33.8 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 32.2 | 96.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 30.7 | 122.7 | GO:0097001 | ceramide binding(GO:0097001) |
| 30.1 | 90.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 30.0 | 90.0 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 29.9 | 29.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 29.7 | 148.6 | GO:0004803 | transposase activity(GO:0004803) |
| 29.0 | 115.9 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 29.0 | 86.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 28.8 | 115.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 28.1 | 84.4 | GO:0032093 | SAM domain binding(GO:0032093) |
| 27.6 | 110.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 26.7 | 80.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 26.2 | 105.0 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 25.3 | 101.0 | GO:0035939 | microsatellite binding(GO:0035939) |
| 24.6 | 24.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 23.7 | 71.2 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 23.0 | 68.9 | GO:0061697 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 22.9 | 91.6 | GO:0004077 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 22.0 | 110.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 22.0 | 197.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 21.6 | 108.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 21.1 | 63.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 20.8 | 62.5 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 19.7 | 236.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 19.4 | 77.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 19.0 | 94.8 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 18.9 | 132.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 18.7 | 56.0 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 18.4 | 147.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 18.0 | 53.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 17.9 | 53.7 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 17.8 | 53.4 | GO:0052835 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 17.7 | 53.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 17.3 | 156.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 17.3 | 190.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 17.2 | 68.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 17.1 | 51.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 17.1 | 68.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 17.0 | 136.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 17.0 | 101.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 16.9 | 135.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 16.7 | 100.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 16.4 | 81.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 16.3 | 65.1 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 16.1 | 48.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 16.0 | 802.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 16.0 | 112.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 16.0 | 144.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 16.0 | 63.9 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 15.7 | 485.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 15.6 | 31.2 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 15.6 | 77.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 15.5 | 31.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 15.5 | 93.1 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 15.5 | 61.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 15.3 | 230.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 15.2 | 121.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 15.1 | 287.4 | GO:0031005 | filamin binding(GO:0031005) |
| 15.0 | 179.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 14.7 | 58.8 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 14.6 | 393.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 14.4 | 57.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 14.3 | 57.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 14.3 | 71.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 14.3 | 42.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 14.1 | 84.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 14.0 | 84.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 14.0 | 41.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 13.9 | 41.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 13.8 | 180.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 13.8 | 55.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 13.5 | 40.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 13.3 | 53.4 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 13.3 | 40.0 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 13.3 | 173.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 13.2 | 52.8 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 13.2 | 92.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 13.1 | 197.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 13.1 | 39.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 13.1 | 39.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 12.7 | 63.6 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 12.7 | 50.6 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 12.6 | 113.4 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 12.2 | 36.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 12.2 | 48.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 12.1 | 194.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 12.1 | 36.4 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 12.0 | 71.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 11.9 | 155.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 11.9 | 47.6 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 11.9 | 59.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 11.8 | 59.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 11.7 | 93.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 11.6 | 23.3 | GO:0051379 | epinephrine binding(GO:0051379) |
| 11.5 | 115.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 11.4 | 45.8 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 11.4 | 171.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 11.4 | 34.1 | GO:0052811 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 11.2 | 101.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 11.2 | 67.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 11.2 | 189.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 11.2 | 33.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 11.1 | 44.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 11.0 | 55.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 11.0 | 77.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 11.0 | 33.0 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 11.0 | 65.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 10.9 | 54.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 10.9 | 21.8 | GO:0033691 | sialic acid binding(GO:0033691) |
| 10.9 | 21.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 10.9 | 65.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 10.8 | 249.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 10.8 | 151.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 10.7 | 53.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 10.6 | 85.0 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 10.6 | 31.7 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 10.5 | 21.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 10.5 | 31.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 10.5 | 31.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 10.5 | 428.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 10.4 | 511.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 10.3 | 51.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 10.2 | 51.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 10.2 | 71.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 10.2 | 91.7 | GO:0016015 | morphogen activity(GO:0016015) |
| 10.0 | 120.3 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 10.0 | 60.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 10.0 | 29.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 9.8 | 333.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 9.8 | 39.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 9.8 | 136.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 9.7 | 29.2 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 9.7 | 19.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 9.7 | 77.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 9.5 | 85.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 9.5 | 85.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 9.5 | 85.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 9.4 | 301.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 9.4 | 65.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 9.3 | 55.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 9.2 | 27.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 9.1 | 209.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
| 9.1 | 54.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 9.0 | 9.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 9.0 | 44.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 9.0 | 80.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 8.9 | 26.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 8.9 | 53.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 8.9 | 124.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 8.9 | 106.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 8.8 | 35.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 8.8 | 52.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 8.8 | 175.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 8.7 | 43.5 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 8.7 | 78.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 8.7 | 26.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 8.5 | 179.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 8.5 | 68.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 8.5 | 50.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 8.4 | 83.8 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 8.3 | 58.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 8.3 | 33.1 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 8.2 | 24.7 | GO:0070984 | SET domain binding(GO:0070984) |
| 8.2 | 41.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 8.2 | 500.4 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 8.2 | 41.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 8.1 | 40.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 8.1 | 24.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 8.0 | 72.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 8.0 | 16.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 8.0 | 136.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 8.0 | 183.3 | GO:0030552 | cAMP binding(GO:0030552) |
| 7.9 | 23.8 | GO:0035473 | lipase binding(GO:0035473) |
| 7.9 | 79.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 7.9 | 31.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 7.8 | 78.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 7.7 | 38.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 7.7 | 23.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 7.7 | 46.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 7.7 | 100.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 7.7 | 184.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 7.7 | 99.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 7.6 | 30.5 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 7.6 | 68.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 7.6 | 15.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 7.5 | 37.5 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 7.5 | 142.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 7.4 | 52.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 7.3 | 219.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 7.3 | 21.9 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 7.3 | 87.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 7.3 | 123.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 7.3 | 21.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 7.3 | 7.3 | GO:0035276 | ethanol binding(GO:0035276) |
| 7.3 | 203.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 7.3 | 108.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 7.3 | 181.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 7.2 | 43.5 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 7.2 | 79.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 7.2 | 28.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 7.2 | 122.8 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 7.2 | 57.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 7.2 | 215.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 7.1 | 128.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 7.1 | 35.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 7.1 | 169.5 | GO:0043274 | phospholipase binding(GO:0043274) |
| 7.0 | 21.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 7.0 | 41.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 7.0 | 20.9 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 6.9 | 13.9 | GO:0043199 | sulfate binding(GO:0043199) |
| 6.9 | 27.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 6.9 | 165.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 6.9 | 68.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 6.8 | 13.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 6.8 | 40.7 | GO:0039552 | RIG-I binding(GO:0039552) |
| 6.8 | 54.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 6.8 | 87.8 | GO:0019841 | retinol binding(GO:0019841) |
| 6.8 | 27.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 6.7 | 26.9 | GO:0038132 | neuregulin binding(GO:0038132) |
| 6.7 | 13.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 6.7 | 20.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 6.7 | 336.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 6.7 | 73.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 6.7 | 20.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 6.7 | 93.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 6.6 | 26.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 6.6 | 33.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 6.6 | 19.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 6.6 | 138.3 | GO:0005112 | Notch binding(GO:0005112) |
| 6.6 | 32.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 6.5 | 78.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 6.5 | 6.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 6.5 | 71.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 6.5 | 32.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 6.5 | 39.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 6.5 | 51.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 6.4 | 51.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 6.4 | 32.2 | GO:0000150 | recombinase activity(GO:0000150) |
| 6.4 | 19.3 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 6.4 | 179.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 6.4 | 63.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 6.3 | 31.7 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 6.3 | 6.3 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 6.3 | 18.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 6.3 | 31.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 6.3 | 6.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 6.2 | 31.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 6.2 | 24.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 6.2 | 73.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 6.2 | 24.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 6.1 | 18.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 6.1 | 49.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 6.1 | 55.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 6.1 | 6.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 6.1 | 103.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 6.1 | 709.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 6.1 | 24.2 | GO:0047708 | biotinidase activity(GO:0047708) |
| 6.1 | 48.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 6.1 | 30.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 6.0 | 18.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 6.0 | 18.1 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 6.0 | 84.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 6.0 | 60.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 6.0 | 42.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 5.9 | 11.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 5.8 | 5.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 5.8 | 52.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 5.8 | 34.9 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 5.8 | 11.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 5.8 | 133.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 5.8 | 34.7 | GO:0048495 | Roundabout binding(GO:0048495) |
| 5.8 | 17.3 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 5.8 | 17.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 5.8 | 86.3 | GO:0015250 | water channel activity(GO:0015250) |
| 5.7 | 40.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 5.7 | 17.1 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 5.7 | 28.3 | GO:0097016 | L27 domain binding(GO:0097016) |
| 5.7 | 5.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 5.7 | 22.6 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 5.6 | 45.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 5.6 | 16.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 5.6 | 16.8 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 5.6 | 16.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 5.6 | 27.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 5.6 | 277.6 | GO:0030507 | spectrin binding(GO:0030507) |
| 5.5 | 160.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 5.5 | 22.2 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 5.5 | 33.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 5.5 | 27.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 5.5 | 16.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 5.5 | 11.0 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 5.5 | 98.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 5.4 | 65.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 5.4 | 27.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 5.4 | 26.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 5.3 | 74.8 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
| 5.3 | 53.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 5.3 | 47.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 5.3 | 37.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 5.2 | 63.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 5.2 | 31.4 | GO:0070728 | leucine binding(GO:0070728) |
| 5.2 | 36.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 5.2 | 15.6 | GO:0017129 | triglyceride binding(GO:0017129) |
| 5.2 | 88.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 5.2 | 25.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 5.2 | 20.7 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 5.1 | 142.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 5.1 | 177.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 5.1 | 40.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 5.0 | 70.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 5.0 | 20.2 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 5.0 | 5.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
| 5.0 | 15.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 5.0 | 169.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 5.0 | 44.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 5.0 | 39.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 5.0 | 14.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 4.9 | 24.7 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 4.9 | 14.7 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 4.9 | 24.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 4.9 | 14.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 4.9 | 4.9 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 4.8 | 4.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 4.8 | 28.9 | GO:0004359 | glutaminase activity(GO:0004359) |
| 4.8 | 28.7 | GO:0030172 | troponin C binding(GO:0030172) |
| 4.8 | 14.3 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 4.7 | 23.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 4.7 | 14.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 4.7 | 61.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 4.7 | 42.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 4.7 | 112.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 4.7 | 28.0 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 4.7 | 84.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 4.7 | 23.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 4.6 | 110.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 4.6 | 4.6 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 4.6 | 259.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 4.5 | 4.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 4.5 | 86.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 4.5 | 13.6 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 4.5 | 22.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 4.5 | 18.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 4.5 | 31.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 4.4 | 31.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 4.4 | 31.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 4.4 | 4.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 4.4 | 48.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 4.4 | 30.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 4.4 | 17.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 4.4 | 17.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 4.4 | 39.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 4.4 | 43.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 4.3 | 21.7 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 4.3 | 39.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 4.3 | 68.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 4.3 | 25.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 4.3 | 255.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 4.3 | 8.5 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 4.2 | 25.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 4.2 | 46.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 4.2 | 29.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 4.2 | 29.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 4.2 | 25.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 4.2 | 21.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 4.2 | 218.7 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
| 4.2 | 12.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) Toll-like receptor 2 binding(GO:0035663) |
| 4.2 | 21.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 4.2 | 75.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 4.2 | 16.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 4.2 | 29.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 4.1 | 20.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 4.1 | 33.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 4.1 | 82.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 4.1 | 275.5 | GO:0019905 | syntaxin binding(GO:0019905) |
| 4.1 | 12.3 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 4.1 | 65.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 4.1 | 4.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 4.1 | 20.4 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 4.1 | 32.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 4.1 | 28.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 4.0 | 52.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 4.0 | 8.0 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 4.0 | 16.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 4.0 | 40.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 4.0 | 8.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 4.0 | 95.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 4.0 | 4.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 3.9 | 15.7 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 3.9 | 23.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 3.9 | 19.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 3.9 | 73.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 3.9 | 11.6 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 3.9 | 46.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 3.9 | 23.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 3.9 | 15.4 | GO:0008142 | oxysterol binding(GO:0008142) |
| 3.9 | 42.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 3.8 | 19.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 3.8 | 319.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 3.8 | 42.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 3.8 | 80.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 3.8 | 11.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 3.8 | 19.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 3.8 | 11.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 3.8 | 248.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 3.8 | 11.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 3.8 | 30.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 3.7 | 108.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
| 3.7 | 70.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 3.7 | 52.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 3.7 | 14.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 3.7 | 63.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 3.7 | 11.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 3.7 | 11.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 3.7 | 59.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 3.7 | 122.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 3.7 | 114.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 3.7 | 18.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 3.6 | 47.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 3.6 | 18.2 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 3.6 | 25.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 3.6 | 14.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 3.6 | 43.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 3.6 | 53.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 3.6 | 7.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 3.5 | 31.8 | GO:0016594 | glycine binding(GO:0016594) |
| 3.5 | 115.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 3.5 | 7.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 3.5 | 104.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 3.5 | 6.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 3.5 | 114.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 3.4 | 72.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 3.4 | 6.9 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 3.4 | 10.2 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 3.4 | 13.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 3.4 | 13.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 3.4 | 30.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 3.4 | 13.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 3.4 | 20.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 3.4 | 10.1 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 3.3 | 16.5 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 3.3 | 9.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 3.3 | 19.7 | GO:0043426 | MRF binding(GO:0043426) |
| 3.3 | 13.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 3.3 | 19.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 3.2 | 55.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 3.2 | 12.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 3.2 | 9.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 3.2 | 48.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 3.2 | 22.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 3.2 | 6.4 | GO:0010851 | cyclase regulator activity(GO:0010851) |
| 3.2 | 19.0 | GO:0034711 | inhibin binding(GO:0034711) |
| 3.2 | 25.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 3.2 | 15.8 | GO:0016918 | retinal binding(GO:0016918) |
| 3.2 | 12.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 3.1 | 62.3 | GO:0005522 | profilin binding(GO:0005522) |
| 3.1 | 27.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 3.1 | 6.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 3.1 | 15.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 3.1 | 12.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 3.0 | 21.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 3.0 | 18.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 3.0 | 12.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 3.0 | 9.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 3.0 | 11.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 3.0 | 14.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 3.0 | 8.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 3.0 | 14.8 | GO:0030553 | cGMP-dependent protein kinase activity(GO:0004692) cGMP binding(GO:0030553) |
| 2.9 | 26.4 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 2.9 | 8.8 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 2.9 | 20.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 2.9 | 20.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 2.9 | 17.2 | GO:0017040 | ceramidase activity(GO:0017040) |
| 2.9 | 31.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 2.9 | 14.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 2.9 | 17.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 2.8 | 324.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 2.8 | 8.5 | GO:0002046 | opsin binding(GO:0002046) |
| 2.8 | 14.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 2.8 | 14.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 2.8 | 50.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 2.8 | 38.8 | GO:0031996 | thioesterase binding(GO:0031996) |
| 2.8 | 13.8 | GO:0070061 | fructose binding(GO:0070061) |
| 2.8 | 27.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 2.8 | 33.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 2.8 | 8.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 2.8 | 41.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 2.7 | 60.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 2.7 | 10.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 2.7 | 2.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 2.7 | 10.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 2.7 | 18.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 2.6 | 13.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 2.6 | 29.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 2.6 | 2.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 2.6 | 47.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 2.6 | 33.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 2.6 | 7.8 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 2.6 | 18.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 2.6 | 41.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 2.6 | 10.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 2.6 | 28.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 2.6 | 43.5 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
| 2.6 | 311.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 2.5 | 17.8 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 2.5 | 12.7 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 2.5 | 7.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 2.5 | 190.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 2.5 | 10.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 2.5 | 12.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 2.5 | 17.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 2.5 | 4.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 2.4 | 52.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 2.3 | 9.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
| 2.3 | 32.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 2.3 | 13.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 2.3 | 59.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 2.3 | 57.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 2.3 | 11.3 | GO:0048185 | activin binding(GO:0048185) |
| 2.3 | 15.9 | GO:0045545 | syndecan binding(GO:0045545) |
| 2.3 | 6.8 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 2.3 | 9.0 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
| 2.2 | 11.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 2.2 | 13.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 2.2 | 6.6 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 2.2 | 8.8 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 2.2 | 35.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 2.2 | 217.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 2.2 | 8.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 2.2 | 43.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 2.2 | 88.3 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
| 2.2 | 17.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 2.1 | 2.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 2.1 | 6.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 2.1 | 62.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 2.1 | 8.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 2.1 | 18.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 2.0 | 12.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 2.0 | 6.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 2.0 | 60.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 2.0 | 14.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 2.0 | 30.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 2.0 | 8.1 | GO:0045569 | TRAIL binding(GO:0045569) |
| 2.0 | 4.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) arginine binding(GO:0034618) |
| 2.0 | 2.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 2.0 | 3.9 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 2.0 | 7.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 2.0 | 3.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 1.9 | 5.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 1.9 | 15.6 | GO:1990405 | protein antigen binding(GO:1990405) |
| 1.9 | 673.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 1.9 | 17.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 1.9 | 3.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 1.9 | 5.7 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.9 | 33.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 1.9 | 9.3 | GO:0008373 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) sialyltransferase activity(GO:0008373) |
| 1.9 | 7.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 1.9 | 242.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 1.8 | 5.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 1.8 | 5.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 1.8 | 1.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 1.8 | 5.5 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 1.8 | 1.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 1.8 | 7.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.8 | 27.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 1.8 | 28.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 1.8 | 17.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 1.8 | 336.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 1.8 | 24.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 1.8 | 28.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 1.7 | 10.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 1.7 | 10.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 1.7 | 5.0 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 1.6 | 18.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 1.6 | 19.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 1.6 | 1.6 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 1.6 | 19.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 1.6 | 1.6 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
| 1.6 | 3.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.6 | 3.2 | GO:0004040 | amidase activity(GO:0004040) |
| 1.6 | 4.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 1.6 | 7.9 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 1.6 | 17.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 1.5 | 23.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 1.5 | 6.2 | GO:0016972 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 1.5 | 23.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 1.5 | 3.1 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.5 | 9.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 1.5 | 3.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 1.5 | 12.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 1.5 | 3.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 1.5 | 40.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 1.5 | 5.9 | GO:0005499 | vitamin D binding(GO:0005499) |
| 1.4 | 4.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 1.4 | 4.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 1.4 | 7.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 1.4 | 4.3 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 1.4 | 4.3 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 1.4 | 39.8 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 1.4 | 149.3 | GO:0005516 | calmodulin binding(GO:0005516) |
| 1.4 | 8.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 1.4 | 4.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 1.4 | 31.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 1.4 | 5.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 1.3 | 8.1 | GO:0008430 | selenium binding(GO:0008430) |
| 1.3 | 17.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 1.3 | 5.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 1.3 | 13.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 1.3 | 18.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 1.3 | 7.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.3 | 32.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 1.3 | 3.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 1.3 | 15.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 1.3 | 3.8 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 1.3 | 23.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 1.2 | 3.7 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
| 1.2 | 4.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 1.2 | 7.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.2 | 6.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 1.2 | 1.2 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 1.2 | 15.4 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
| 1.2 | 70.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 1.2 | 4.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 1.2 | 17.5 | GO:0051184 | cofactor transporter activity(GO:0051184) |
| 1.2 | 5.8 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 1.2 | 10.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 1.1 | 20.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 1.1 | 71.6 | GO:0035064 | methylated histone binding(GO:0035064) |
| 1.1 | 5.6 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.1 | 30.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 1.1 | 2.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 1.1 | 14.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 1.1 | 2.1 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 1.0 | 6.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 1.0 | 231.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 1.0 | 22.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 1.0 | 16.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 1.0 | 5.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 1.0 | 2.0 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 1.0 | 3.0 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.0 | 2.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 1.0 | 17.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 1.0 | 84.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 1.0 | 7.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 1.0 | 1.0 | GO:0042806 | fucose binding(GO:0042806) |
| 0.9 | 8.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.9 | 0.9 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.9 | 37.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.9 | 63.4 | GO:0005179 | hormone activity(GO:0005179) |
| 0.9 | 14.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.9 | 34.1 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.9 | 1.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.9 | 2.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.8 | 5.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.8 | 10.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.8 | 24.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.8 | 1.7 | GO:0022834 | ligand-gated ion channel activity(GO:0015276) ligand-gated channel activity(GO:0022834) |
| 0.8 | 43.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.8 | 4.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.8 | 3.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.8 | 31.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.8 | 5.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.7 | 2.2 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.7 | 9.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.7 | 3.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.7 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.7 | 5.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.7 | 6.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.7 | 46.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.7 | 10.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
| 0.7 | 825.8 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.7 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.7 | 4.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.7 | 2.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.7 | 8.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.6 | 2.6 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.6 | 1.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.6 | 1.8 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.6 | 2.3 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.6 | 14.9 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.6 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 2.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
| 0.6 | 2.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.5 | 14.8 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.5 | 3.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.5 | 15.3 | GO:0042805 | actinin binding(GO:0042805) |
| 0.5 | 6.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.5 | 3.8 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.5 | 1.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.5 | 0.9 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.4 | 2.2 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.4 | 2.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.4 | 5.1 | GO:0017022 | myosin binding(GO:0017022) |
| 0.4 | 1.7 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.4 | 4.2 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.4 | 5.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.4 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.4 | 16.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.4 | 0.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.4 | 189.4 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.4 | 1.1 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.3 | 6.6 | GO:0019838 | growth factor binding(GO:0019838) |
| 0.3 | 0.3 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.3 | 11.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.3 | 1.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.3 | 0.6 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.3 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.3 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.3 | 0.8 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.3 | 3.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.3 | 6.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 1.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.2 | 0.6 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
| 0.2 | 1.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.2 | 12.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.2 | 4.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 0.8 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.4 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 21.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 1.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.0 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
| 0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.0 | 0.0 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 51.5 | 51.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 18.1 | 762.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 15.2 | 15.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 14.1 | 169.5 | ST GAQ PATHWAY | G alpha q Pathway |
| 9.9 | 238.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 8.7 | 243.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 8.6 | 456.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 8.4 | 41.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 8.1 | 32.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 7.7 | 176.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 7.5 | 14.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 7.3 | 80.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 6.7 | 414.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 6.3 | 6.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 6.1 | 85.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 6.0 | 555.0 | PID FGF PATHWAY | FGF signaling pathway |
| 5.9 | 283.7 | NABA COLLAGENS | Genes encoding collagen proteins |
| 5.8 | 192.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 5.7 | 17.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 5.5 | 328.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 5.3 | 31.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 5.3 | 10.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 5.1 | 30.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 5.1 | 25.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 4.9 | 252.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 4.7 | 9.4 | ST STAT3 PATHWAY | STAT3 Pathway |
| 4.7 | 46.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 4.6 | 96.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 4.6 | 123.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 4.5 | 163.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 4.4 | 83.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 4.4 | 26.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 4.3 | 68.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 4.3 | 362.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 4.2 | 74.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 4.2 | 161.9 | PID REELIN PATHWAY | Reelin signaling pathway |
| 4.1 | 111.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 4.1 | 181.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 4.1 | 36.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 4.0 | 286.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 4.0 | 187.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 3.9 | 74.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 3.8 | 26.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 3.8 | 94.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 3.7 | 210.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 3.7 | 51.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 3.7 | 749.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 3.6 | 83.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 3.6 | 10.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 3.6 | 14.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 3.4 | 58.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 3.3 | 73.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 3.3 | 26.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 3.3 | 32.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 3.2 | 63.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 3.1 | 24.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 2.9 | 94.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 2.9 | 99.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 2.9 | 84.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 2.8 | 51.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 2.8 | 64.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 2.8 | 2.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 2.7 | 30.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 2.7 | 54.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 2.7 | 26.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 2.6 | 56.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 2.5 | 52.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 2.5 | 57.1 | PID INSULIN PATHWAY | Insulin Pathway |
| 2.4 | 105.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 2.4 | 4.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 2.3 | 740.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 2.3 | 11.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 2.2 | 218.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 2.1 | 32.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 2.1 | 55.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 2.1 | 78.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 2.1 | 21.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 2.1 | 16.5 | PID NOTCH PATHWAY | Notch signaling pathway |
| 2.1 | 82.1 | PID LKB1 PATHWAY | LKB1 signaling events |
| 2.0 | 16.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 2.0 | 6.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 2.0 | 30.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 1.9 | 22.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 1.9 | 38.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 1.8 | 72.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 1.8 | 39.6 | PID ENDOTHELIN PATHWAY | Endothelins |
| 1.8 | 32.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 1.7 | 6.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.7 | 32.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 1.6 | 262.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 1.5 | 49.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 1.4 | 380.6 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 1.4 | 16.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 1.3 | 75.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 1.1 | 14.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 1.1 | 22.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.9 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.9 | 44.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.9 | 12.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.9 | 19.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.8 | 1.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.8 | 19.4 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.8 | 9.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.7 | 17.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.7 | 7.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.6 | 9.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.5 | 17.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.5 | 4.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.4 | 5.6 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.3 | 5.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.3 | 1.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 25.2 | 580.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 21.0 | 21.0 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
| 21.0 | 21.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 20.2 | 647.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 17.7 | 17.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 16.6 | 16.6 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
| 16.1 | 450.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 15.8 | 205.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 15.4 | 662.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 14.6 | 292.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 13.9 | 751.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 13.8 | 41.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 13.2 | 171.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 12.6 | 517.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 11.8 | 11.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 11.6 | 81.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 11.4 | 113.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 11.3 | 78.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 10.8 | 21.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 10.0 | 230.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 9.7 | 58.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 9.7 | 115.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 9.0 | 144.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 9.0 | 125.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 8.5 | 127.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 8.3 | 133.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 8.3 | 314.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 8.1 | 217.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 8.0 | 289.8 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 7.9 | 198.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 7.8 | 62.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 7.7 | 115.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 7.7 | 562.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 7.6 | 237.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 7.6 | 38.1 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
| 7.6 | 317.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 7.4 | 162.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 7.1 | 135.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 7.0 | 112.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 6.8 | 135.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 6.7 | 160.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 6.5 | 149.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 6.4 | 108.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 6.4 | 127.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 6.3 | 341.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 6.3 | 62.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 6.1 | 60.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 6.0 | 277.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 6.0 | 6.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 5.8 | 5.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 5.6 | 73.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 5.6 | 124.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 5.5 | 165.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 5.3 | 170.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 5.3 | 216.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 5.3 | 110.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 5.2 | 123.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 5.0 | 75.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 5.0 | 64.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 4.9 | 29.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 4.8 | 129.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 4.8 | 536.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 4.7 | 9.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 4.6 | 564.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 4.5 | 4.5 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
| 4.5 | 77.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 4.5 | 9.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 4.3 | 94.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 4.3 | 77.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 4.3 | 4.3 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
| 4.2 | 501.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 4.2 | 691.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 4.1 | 65.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 3.9 | 98.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 3.9 | 85.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 3.9 | 3.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 3.9 | 7.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 3.8 | 133.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 3.7 | 67.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 3.7 | 40.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 3.6 | 115.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 3.5 | 63.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 3.5 | 56.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 3.5 | 126.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 3.4 | 152.9 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 3.4 | 144.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 3.3 | 59.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 3.3 | 145.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 3.3 | 32.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 3.2 | 126.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 3.2 | 57.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 3.2 | 22.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 3.1 | 52.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 3.0 | 24.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 2.9 | 235.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 2.8 | 5.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 2.8 | 11.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 2.8 | 102.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 2.8 | 30.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 2.7 | 19.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 2.7 | 62.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 2.7 | 270.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 2.7 | 2.7 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 2.6 | 154.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 2.6 | 46.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 2.5 | 22.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 2.5 | 10.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 2.5 | 5.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 2.5 | 22.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 2.4 | 29.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 2.4 | 33.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 2.4 | 55.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 2.4 | 36.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 2.4 | 16.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 2.3 | 18.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 2.2 | 17.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 2.2 | 4.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 2.0 | 32.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 1.8 | 34.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 1.7 | 38.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 1.7 | 132.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 1.6 | 18.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 1.6 | 31.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 1.5 | 4.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 1.5 | 9.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.5 | 31.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 1.4 | 11.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 1.4 | 4.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 1.4 | 21.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 1.3 | 7.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 1.3 | 6.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 1.3 | 3.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 1.3 | 10.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 1.2 | 3.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 1.1 | 21.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 1.1 | 14.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 1.1 | 14.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 1.0 | 26.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 1.0 | 17.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 1.0 | 10.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 1.0 | 6.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 1.0 | 6.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.9 | 17.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.9 | 12.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.9 | 9.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.8 | 17.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.8 | 2.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.8 | 250.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.8 | 15.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.7 | 2.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.7 | 19.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.7 | 3.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.6 | 12.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.6 | 14.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.5 | 10.3 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
| 0.5 | 6.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.5 | 8.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.5 | 8.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.5 | 18.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.4 | 7.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.4 | 45.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.4 | 2.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.3 | 9.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.3 | 4.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 22.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.3 | 5.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 7.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 3.3 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.2 | 5.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 4.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 1.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.1 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.0 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.0 | 0.9 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |